Cogenics partners to bring genomic services to China

By Nick Taylor

- Last updated on GMT

Related tags Genetics

Cogenics has entered into a partnership with SinoGenoMax to bring its clinical genotyping services to the expanding Chinese market.

By partnering with an established force in the Chinese genomics market Cogenics is hoping to gain access to clients beyond its primary markets in the US and Europe.

SinoGenoMax provides genomic services to local and international universities, research institutes and pharmaceutical companies. The partnership should give Cogenics access to these clients and expand the range of services that the companies can offer.

Michael Lutz, Global Manager of Cogenics, said: “The extensive pharmaceutical and biotechnology infrastructure and large number of clinical trials conducted in China make this an increasingly important market for clinical genotyping services​.

Our partnership with SinoGenoMax provides us with an established presence in China and an experienced international service partner who operates with similar platforms and high quality standards, thus expanding Cogenics’ offering to our growing global pharmaceutical customer base​.”

Cogenics claims its clients include the top 20 pharmaceutical companies operating in the US and Europe. Companies in China will now have greater access to these services, which include next generation sequencing, gene expression and clinical and non-clinical genotyping.

In addition Cogenics can provide biomanufacturing support, nucleic acid extraction and biobanking for research and regulated environments.

Cogenics entry into China suggests it believes that the number of clinical trials conducted in the country will continue to grow, driving demand for related services.

Related news

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us

Webinars

Headlines